BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 63315)

  • 1. Simultaneous assays of cancer-associated antigens in various neoplastic disorders.
    Franchimont P; Zangerle PF; Nogarede J; Bury J; Molter F; Reuter A; Hendrick JC; Collette J
    Cancer; 1976 Dec; 38(6):2287-95. PubMed ID: 63315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Casein and other tumor markers in relation to cancer of the breast.
    Zangerle PF; Thirion A; Hendrick JC; Franchimont P
    Antibiot Chemother (1971); 1978; 22():141-8. PubMed ID: 74972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous assays of cancer associated antigens in benign and malignant breast diseases.
    Franchimont P; Zangerle PF; Hendrick JC; Reuter A; Colin C
    Cancer; 1977 Jun; 39(6 Suppl):2806-12. PubMed ID: 68808
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum biochemical markers in lung cancer.
    Burt RW; Ratcliffe JG; Stack BH; Cuthbert J; Kennedy RS; Corker CS; Franchimont P; Spilg WG; Stimson WH
    Br J Cancer; 1978 May; 37(5):714-7. PubMed ID: 77672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated antigen levels (carcinoembryonic antigen, human chorionic gonadotropin, and alpha-fetoprotein) antedating the diagnosis of cancer in the Framingham study.
    Williams RR; McIntire KR; Waldmann TA; Feinleib M; Go VL; Kannel WB; Dawber TR; Castelli WP; McNamara PM
    J Natl Cancer Inst; 1977 Jun; 58(6):1547-51. PubMed ID: 68118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A primary lung carcinoma producing alpha-fetoprotein, carcinoembryonic antigen, and human chorionic gonadotropin. Immunohistochemical and biochemical studies.
    Yoshimoto T; Higashino K; Hada T; Tamura S; Nakanishi K; Mitsunobu M; Uematsu K; Matsuoka T; Taketa K
    Cancer; 1987 Dec; 60(11):2744-50. PubMed ID: 2445464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEA, AFP and other potential tumor markers.
    Zamcheck N; Pusztaszeri G
    CA Cancer J Clin; 1975; 25(4):204-14. PubMed ID: 48409
    [No Abstract]   [Full Text] [Related]  

  • 9. alpha-Fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) demonstrated in the immature glands of mediastinal teratocarcinoma: a case report.
    Irie T; Watanabe H; Kawaoi A; Takeuchi J
    Cancer; 1982 Sep; 50(6):1160-5. PubMed ID: 6179592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncofetal antigens. Increasing the specificity of the CEA radioimmunoassay.
    Shuster J; Freedman SO; Gold P
    Am J Clin Pathol; 1977 Nov; 68(5 Suppl):679-87. PubMed ID: 72501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncofetal antigens in sacrococcygeal teratomas.
    Kuhajda FP; Taxy JB
    Arch Pathol Lab Med; 1983 May; 107(5):239-42. PubMed ID: 6188436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor markers: value and limitations in the management of cancer patients.
    Bates SE; Longo DL
    Cancer Treat Rev; 1985 Sep; 12(3):163-207. PubMed ID: 2416441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical demonstration of several tumour markers in neoplastic and preneoplastic states of the uterine mucosa.
    Hustin J
    Gynecol Obstet Invest; 1978; 9(1):3-15. PubMed ID: 81793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human chorionic gonadotropin in gastric carcinoma. A useful marker for bone metastasis.
    Yonemura Y; Oyama S; Sugiyama K; Sawa T; Shima Y; Kamata T; Hashimoto T; Miwa K; Miyazaki I
    Int Surg; 1989; 74(2):84-7. PubMed ID: 2473961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating tumor antigens.
    Egan ML; Engvall E; Ruoslahti EI; Todd CW
    Cancer; 1977 Jul; 40(1 Suppl):458-66. PubMed ID: 69486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM; Heatfield BM; Trump BF
    Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CEA serum level in patients with liver diseases].
    Lamerz R
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1201-4. PubMed ID: 206044
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
    Hayes DF; Zurawski VR; Kufe DW
    J Clin Oncol; 1986 Oct; 4(10):1542-50. PubMed ID: 2428949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical localization of carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and human chorionic gonadotropin (HCG) in cervical neoplasia.
    Bychkov V; Rothman M; Bardawil WA
    Am J Clin Pathol; 1983 Apr; 79(4):414-20. PubMed ID: 6188359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
    Kuusela P; Haglund C; Roberts PJ; Jalanko H
    Br J Cancer; 1987 Jun; 55(6):673-6. PubMed ID: 2441731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.